Delivery Order SPE2DR25D1100-SPE2DR26FCS8L
Award Date 12/4/25
Potential Completion Date 12/5/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $11,806.14 to AmerisourceBergen Drug Corp for the supply of Rexulti 3 mg tablets (30-count units) on December 3, 2025, with completion scheduled for December 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $5,534.04 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count packages) under a firm fixed-price contract. This non-set-aside award was issued on December 3, 2025, with an ultimate completion date of December 4, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution center for federal pharmaceutical...
- The Defense Logistics Agency awarded a $39,573.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (quantity 30) on December 1, 2025, with an ultimate completion date of December 2, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Rexulti 2 mg tablets (quantity: 30 units) with a ceiling value of $2,927.61. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Rexulti 0.5 mg tablets (30-count) with a ceiling value of $1,952.46. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive process. The contract is due for completion by August 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order under the company's...
- The Defense Logistics Agency awarded a $2,927.91 delivery order to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreements. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $5,066.14 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count package) on November 14, 2025. This firm fixed-price delivery order, which is part of a larger competitively awarded contract vehicle, will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with completion targeted for November 17, 2025. The contract includes no set-aside designation, reflecting open competition...
- The Defense Logistics Agency awarded a delivery order valued at $13,026.20 to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Rexulti 3 mg tablets (30-count units). This firm fixed-price, non-competitive delivery order is scheduled for completion by June 30, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $8,122.46 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside award was issued on October 17, 2025, with an ultimate completion date of October 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the performer of record for this delivery order. This award represents a child contract action under the company's larger...
- The Defense Logistics Agency awarded a Delivery Order valued at $2,783.93 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order represents a single transaction under AmerisourceBergen Drug Corp's larger...